Deal follows turbulence at RStarFilm company 3M is making moves to expand its line of PACS offeringsbeyond those available through its relationship with RStar. 3Mlast week announced that it had signed a joint sales and marketingagreement with
Film company 3M is making moves to expand its line of PACS offeringsbeyond those available through its relationship with RStar. 3Mlast week announced that it had signed a joint sales and marketingagreement with PACS developer Cemax.
The deal comes only months after 3M rolled out the RStar-developedline, called 3M PACS for ICU/CCU/ER, at last year's RadiologicalSociety of North America meeting.
RStar is a for-profit spinoff of Massachusetts General Hospital.Its system is intended for high-end hospital PACS, featuring MacintoshQuadra workstations with proprietary RStar display controllers.RStar experienced rough sledding last year, however. An executivehousecleaning in March removed four executives, including presidentJames Taaffe, who developed much of the RStar hardware and software(SCAN 4/7/93).
The changes were such that 3M was compelled later in the yearto announce that it was "aggressively moving forward"with the RStar technology (SCAN 7/14/93). The scuttlebutt at lastyear's RSNA, however, was that 3M was looking for a new PACS partner.
Cemax would fit that bill perfectly. The software developerhas had success securing OEM relationships for its Perfect VisionSeries of object-oriented fully distributed PACS products. Underthe terms of the agreement with 3M, the companies will work togetherto offer combined 3M/Cemax systems. The companies will coordinatesales of 3M imaging products and Cemax's Perfect Vision Series,including the ImageServer, ClinicalView, RadView, HomeView, NetworkFilmServerand ArchiveManager products. "Cemax and 3M have a sharedvision of how to most effectively manage an image network,"said Bob Harms, 3M Medical Imaging Systems vice president. "Bycombining our resources to develop this vision, our customerswill realize greater flexibility, more practical solutions andlower cost through joint effort."
Whether that vision includes RStar is unclear, however. A 3Mnews release on the Cemax agreement did not mention the statusof the company's alliance with RStar, and 3M representatives werenot available for comment at press time.
Can Abbreviated MRI Have an Impact in Rectal Cancer Staging?
April 4th 2025Abbreviated MRI demonstrated a 95.3 percent specificity for rectal cancer and provided strong agreement with the full MRI protocol for T staging and detection of extramural venous invasion, according to newly published research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.